Regeneron Pharmaceuticals Inc (NASDAQ:REGN)
| 544.16 BATS BZX Real-Time Price As of 11:15am ET |  -4.56 / -0.83%Today’s Change | 328.13 Today|||52-Week Range 664.64 | +12.64% Year-to-Date |
Latest REGN News | Press Releases
Today’s Trading
| Previous close | 548.72 |
| Today’s open | 557.18 |
| Day’s range | 544.10 - 557.18 |
| Volume | 15,212 |
| Average volume (3 months) | 989,283 |
| Market cap | $57.4B |
Data as of 11:15am ET, 01/26/2021
Growth & Valuation
| Earnings growth (last year) | -14.46% |
| Earnings growth (this year) | +23.63% |
| Earnings growth (next 5 years) | +8.25% |
| Revenue growth (last year) | +17.18% |
| P/E ratio | 20.0 |
| Price/Sales | 5.47 |
| Price/Book | 5.35 |
Competitors
Data as of 11:15am ET, 01/26/2021
Financials
| Next reporting date | February 5, 2021 |
| EPS forecast (this quarter) | $8.23 |
| Annual revenue (last year) | $7.9B |
| Annual profit (last year) | $2.1B |
| Net profit margin | 26.91% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Tarrytown, New York |
Forecasts
